Engineered gut bacteria helped activate immune attacks against pancreatic tumors in animal models. Pancreatic tumors are notoriously difficult for the immune system to attack. They often create a “cold” tumor microenvironment that keeps immune cells from building an effective response,…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.